Reata Pharmaceuticals, Inc.
RETA · NASDAQ
12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$312 | -$297 | -$248 | -$290 |
| Dep. & Amort. | $1 | $1 | $1 | $1 |
| Deferred Tax | $0 | $0 | $11 | $0 |
| Stock-Based Comp. | $59 | $57 | $58 | $26 |
| Change in WC | $9 | -$50 | -$173 | $10 |
| Other Non-Cash | $38 | $53 | $28 | $1 |
| Operating Cash Flow | -$204 | -$236 | -$322 | -$251 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$3 | -$1 | -$1 | -$3 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | -$662 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $320 | $0 | $0 | $0 |
| Other Inv. Act. | $0 | $0 | $0 | $0 |
| Investing Cash Flow | -$345 | -$1 | -$1 | -$3 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $0 | $333 | $333 | $492 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $1 | $9 | $477 | $580 |
| Financing Cash Flow | $1 | $9 | $477 | $580 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | -$548 | -$228 | $154 | $327 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $590 | $818 | $664 | $338 |
| End Cash | $42 | $590 | $818 | $664 |
| Free Cash Flow | -$208 | -$237 | -$323 | -$254 |